MedPharm

MedPharm is a leading Contract Development and Manufacturing Organization (CDMO) specializing in the development and manufacturing of topical, transdermal, and mucosal drug products. Established in 1999 within the scientific community at King’s College London, the company has grown into a globally recognized entity with state-of-the-art facilities in Guildford, UK, and Durham, North Carolina, USA.

The company offers a comprehensive suite of services that encompass the entire drug development lifecycle. These services include formulation development, analytical testing, in vitro performance testing, clinical trial manufacturing, and commercial production.

MedPharm's expertise spans various drug delivery routes, such as dermal, transdermal, lung, nasal, mucosal membrane, ungual, otic, and ophthalmic applications.

Facilities in Durham, North Carolina

MedPharm's Durham facilities play a pivotal role in its operations. The Stirrup Creek facility, covering 100,000 square feet, focuses on liquid and semi-solid drug product development and manufacturing.

This site provides end-to-end CDMO services for clinical through commercial production, specializing in semi-solid and liquid pharmaceuticals, small molecule drug products, biologic formulations, hormonal therapies, and high-potency active pharmaceutical ingredients (HPAPIs).

The facility features advanced infrastructure, including ISO 8 GMP compounding suites, hormone manufacturing suites, and high-potency suites. These ensure containment, quality, and regulatory compliance throughout all development and production stages.

The Emperor Boulevard facility, with 21,000 square feet, supports pharmaceutical and medical research.

It offers expertise in analytical testing, formulation development, microbiological analysis, tissue-based research, and performance testing.

Specializations at this facility include drug delivery assessment, in vitro permeation and release studies, stability testing, and bioanalytical services to ensure product efficacy, safety, and compliance.

The lab is equipped with advanced equipment such as HPLC/UPLC systems, LC-MS/MS systems, dissolution chambers, and various diffusion cells for in vitro and permeation testing.

Merger and Strategic Growth

In July 2024, MedPharm merged with Tergus Pharma, a Durham-based company specializing in topical pharmaceutical product research, formulation, drug development, testing, and clinical and commercial manufacturing.

This strategic merger has enhanced MedPharm's capabilities, enabling it to offer a more integrated service offering for ophthalmic, topical, and transdermal development and manufacturing projects.

Global Impact and Mission

MedPharm's global reach and commitment to scientific excellence have led to the development and approval of over 85 marketed products across the USA, Europe, and Japan.

The company's mission is to advance patient care by delivering innovative, science-driven solutions guided by integrity, quality, and collaboration.

Locations

• Durham, NC, USA – key center for drug product development, manufacturing, analytical testing, and research